Classification of side-effects to danazol therapy

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (14)

• "Per vaginam" topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review 2017
• Danazol for uterine fibroids 2009
• Danazol for uterine fibroids 2009
• Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository 1995
• A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia 1993
• The detection of danazol and its significance in doping analysis 1992
• Cholestatic jaundice associated with danazol therapy 1992
• A new therapy for pelvic endometriosis and uterine adenomyosis: local effect of vaginal and intrauterine danazol application 1990
• Clinical therapeutics of endometriosis, Part 2 1989
• Effect of danazol on cyclosporine pharmacokinetics 1988
• Treatment of dysfunctional uterine bleeding with danazol 1985
• Side effects of danazol compared with an ethinyloestradiol/norgestrel combination when used for postcoital contraception 1983
• Danazol in the treatment of endometriosis 1980
• Myalgia and elevated creatine phosphokinase with Danazol in hereditary angioedema 1979

Source provenance

openalex

last seen: 2026-05-11T03:53:55.316783+00:00

pubmed

last seen: 2026-10-08T21:02:01.755765+00:00